Chiropractors in Conway, NH Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Anthony A Soriente, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 24 Pleasant Street, Suite 202, Conway, NH 03818 Phone: 603-447-2244 Fax: 603-687-0107 |
 Dr. Juliet C Dickinson, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 45 Washington St, Conway, NH 03818 Phone: 603-447-1144 Fax: 603-447-1133 |
Dr. Shawn Robert Taylor, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 486 White Mountain Hwy, Suite A, Conway, NH 03818 Phone: 603-447-1131 Fax: 603-447-1145 |
 Dr. Juliet Dickinson, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 45 Washington St, Suite 6, Conway, NH 03818 Phone: 603-447-1144 Fax: 603-447-1133 |
Mwv Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 24 Pleasant St Ste 202, Conway, NH 03818 Phone: 603-447-2244 |
Larissa Mara Taylor, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 14 Washington St, Conway, NH 03818 Phone: 603-447-1131 |
News Archive
NIAID, Aeras partner for Phase II clinical trial of TB vaccine
Aeras announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate jointly developed by Aeras and Dutch biopharmaceutical company Crucell.
Personal networks could play a key role in advancing the adoption of cleaner cooking fuel
A new, first-of-its-kind study led by researchers from Boston College has found that personal networks in India could play an important role in advancing the adoption of a cleaner cooking fuel, in this case liquefied petroleum gas, according to a report published in the journal Environmental Research Letters.
Renhuang Pharmaceuticals' Siberian Ginseng capsule patent application passes preliminary SIPO review
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
PATH Blog examines organization's work in malaria through affiliate drug development program
This PATH Blog post examines PATH's work in malaria through OneWorld Health, a non-profit drug development program. Since 2004, "when OneWorld Health formed a partnership to develop an alternative source of the malaria drug artemisinin, ... OneWorld Health, which became an affiliate of PATH late last year, has quietly forged relationships with public and private partners, creating the Artemisinin Project to take the work from research to commercialization," the blog writes.
Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips
Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.
› Verified 2 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Optometrists